Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1 ‐5 trials

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - June 8, 2018 Category: Endocrinology Authors: Mark Warren MD , Louis Chaykin MD , David Trachtenbarg MD , Gurudutt Nayak MD , Nelun Wijayasinghe MD , Bertrand Cariou MD Source Type: research